275 related articles for article (PubMed ID: 15534182)
1. Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study.
Thobois S; Vingerhoets F; Fraix V; Xie-Brustolin J; Mollion H; Costes N; Mertens P; Benabid AL; Pollak P; Broussolle E
Arch Neurol; 2004 Nov; 61(11):1705-9. PubMed ID: 15534182
[TBL] [Abstract][Full Text] [Related]
2. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
[TBL] [Abstract][Full Text] [Related]
3. Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study.
Thobois S; Fraix V; Savasta M; Costes N; Pollak P; Mertens P; Koudsie A; Le Bars D; Benabid AL; Broussolle E
J Neurol; 2003 Oct; 250(10):1219-23. PubMed ID: 14586606
[TBL] [Abstract][Full Text] [Related]
4. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
[TBL] [Abstract][Full Text] [Related]
5. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity.
Hilker R; Schweitzer K; Coburger S; Ghaemi M; Weisenbach S; Jacobs AH; Rudolf J; Herholz K; Heiss WD
Arch Neurol; 2005 Mar; 62(3):378-82. PubMed ID: 15767502
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.
Nimura T; Yamaguchi K; Ando T; Shibuya S; Oikawa T; Nakagawa A; Shirane R; Itoh M; Tominaga T
J Neurosurg; 2005 Dec; 103(6):968-73. PubMed ID: 16381182
[TBL] [Abstract][Full Text] [Related]
7. [Adenosine receptor--relation to dopaminergic system].
Mishina M; Ishii K; Ishiwata K
Rinsho Shinkeigaku; 2007 Nov; 47(11):835-7. PubMed ID: 18210811
[TBL] [Abstract][Full Text] [Related]
8. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease.
Weinberger M; Mahant N; Hutchison WD; Lozano AM; Moro E; Hodaie M; Lang AE; Dostrovsky JO
J Neurophysiol; 2006 Dec; 96(6):3248-56. PubMed ID: 17005611
[TBL] [Abstract][Full Text] [Related]
9. Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease.
Muramatsu S; Okuno T; Suzuki Y; Nakayama T; Kakiuchi T; Takino N; Iida A; Ono F; Terao K; Inoue N; Nakano I; Kondo Y; Tsukada H
Synapse; 2009 Jul; 63(7):541-8. PubMed ID: 19253400
[TBL] [Abstract][Full Text] [Related]
10. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
[TBL] [Abstract][Full Text] [Related]
11. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
Mongeon D; Blanchet P; Messier J
Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
[TBL] [Abstract][Full Text] [Related]
12. Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis.
Lee CS; Schulzer M; de la Fuente-Fernández R; Mak E; Kuramoto L; Sossi V; Ruth TJ; Calne DB; Stoessl AJ
Arch Neurol; 2004 Dec; 61(12):1920-5. PubMed ID: 15596613
[TBL] [Abstract][Full Text] [Related]
13. Localization of dopaminergic markers in the human subthalamic nucleus.
Augood SJ; Hollingsworth ZR; Standaert DG; Emson PC; Penney JB
J Comp Neurol; 2000 May; 421(2):247-55. PubMed ID: 10813785
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
McCormick PN; Kapur S; Seeman P; Wilson AA
Nucl Med Biol; 2008 Jan; 35(1):11-7. PubMed ID: 18158938
[TBL] [Abstract][Full Text] [Related]
15. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in Parkinson's disease: one year follow-up of a randomised observer-blind multi centre trial.
Esselink RA; de Bie RM; de Haan RJ; Steur EN; Beute GN; Portman AT; Schuurman PR; Bosch DA; Speelman JD
Acta Neurochir (Wien); 2006 Dec; 148(12):1247-55; discussion 1255. PubMed ID: 17072792
[TBL] [Abstract][Full Text] [Related]
16. Chronic exposure to dopamine agonists affects the integrity of striatal D
Politis M; Wilson H; Wu K; Brooks DJ; Piccini P
Neuroimage Clin; 2017; 16():455-460. PubMed ID: 28879087
[TBL] [Abstract][Full Text] [Related]
17. Measurement of dopamine D2 receptors in living human brain using [11C]raclopride with ultra-high specific radioactivity.
Fujimura Y; Ito H; Takahashi H; Yasuno F; Ikoma Y; Zhang MR; Nanko S; Suzuki K; Suhara T
Nucl Med Biol; 2010 Oct; 37(7):831-5. PubMed ID: 20870158
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic drugs restore facilitatory premotor-motor interactions in Parkinson disease.
Mir P; Matsunaga K; Gilio F; Quinn NP; Siebner HR; Rothwell JC
Neurology; 2005 Jun; 64(11):1906-12. PubMed ID: 15955942
[TBL] [Abstract][Full Text] [Related]
19. Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease.
Bloem BR; Beckley DJ; van Dijk JG; Zwinderman AH; Remler MP; Roos RA
Mov Disord; 1996 Sep; 11(5):509-21. PubMed ID: 8866492
[TBL] [Abstract][Full Text] [Related]
20. Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats.
Ginovart N; Wilson AA; Houle S; Kapur S
Biol Psychiatry; 2004 Jun; 55(12):1188-94. PubMed ID: 15184038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
